Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice

Molecular Biotechnology

Volumn 35, Issue 3, 2007, Pages 225-235

  Martinez Donato, Gillian ^a   Capdesuñer, Yanelis ^a   Acosta Rivero, Nelson ^a   Rodríguez, Armando ^a   Morales Grillo, Juan ^a   Martínez, Eduardo ^a   González, Marleny ^a   Alvarez Obregon, Julio C ^a   Dueñas Carrera, Santiago ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; IMMUNOLOGY; MEDICAL APPLICATIONS; RATS; VIRUSES;

IMMUNE RESPONSE; IMMUNOREGULATORY; PICHIA PASTORIS CELLS; THERAPEUTICS APPLICATIONS;

PROTEINS;

CD81 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN E2; MONOMER; POLYMER;

ANTIGENICITY; ARTICLE; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PICHIA PASTORIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

HEPATITIS C VIRUS; MUS; PICHIA PASTORIS;

EID: 34547819813     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686008     Document Type: Article

References (40)

1. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., and Houghton, M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
2. Matsuura, Y., Suzuki, T., Suzuki, R., et al. 1994. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205, 141-150.
3. Rosa, D., Campagnoli, S., Moretto, C., et al. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. U.S.A. 93, 1759-1763.
4. Flint, M., Maidens, C., Loomis-Price, L. D., et al. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73, 6235-6244.
5. Lambot, M., Fretier, S., Op, D. B., et al. 2002. Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J. Biol. Chem. 277, 20625-20630.
6. Buonocore, L., Blight, K. J., Rice, C. M., and Rose, J. K. 2002. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J. Virol. 76, 6865-6872.
7. Triyatni, M., Vergalla, J., Davis, A. R., Hadlock, K. G., Foung, S. K., and Liang, T. J. 2002. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 298, 124-132.
8. Choo, Q. L., Kuo, G., Ralston, R., et al. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 91, 1294-1298.
9. Cooper, S., Erickson, A. L., Adams, E. J., et al. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449.
10. Cereghino, G. P., Cereghino, J. L., Ilgen, C., and Cregg, J. M. 2002. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr. Opin. Biotechnol. 13, 329-332.
11. Cregg, J. M., Vedvick, T., and Raschke, W. C. 1993. Recent advances in the expression of foreign gene in Pichia pastoris. Biotechnology 11, 905.
12. Duenas-Carrera, S., Alvarez-Lajonchere, L., Alvarez-Obregon, J. C., et al. 2000. A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization. Vaccine 19, 992-997.
13. Hardy, E., Martinez, E., Diago, D., Diaz, R., Gonzalez, D., and Herrera, L. 2000. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. J. Biotechnol. 77, 157-167.
14. Deleersnyder, V., Pillez, A., Wychowski, C., et al. 1997. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71, 697-704.
15. Patel, A. H., Wood, J., Penin, F., Dubuisson, J., and McKeating, J. A. 2000. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J. Gen. Virol. 81, 2873-2883.
16. Martínez, G., Viña, A., Borges, M., Martínez, E., and Morales, J. 2000. Humoral immune response against a hepatitis C virus envelope E2 variant expressed in Escherichia coli. Biotecnología Aplicada 17, 231-234.
17. García, B., Rodríguez, E., Rivero, T., Hidalgo, Y., and Menéndez, J. 2000. Dextranase expression in two different host-vector systems of the methylotrophic yeast Pichia pastoris. Biotecnología Aplicada 17, 11-15.
18. Morales, J., Viña, A., García, C., et al. Sequences derived from the genome of the hepatitis C virus, and use thereof. European Patent Office. The SPACE WORLD. WO 98/25960. 1998.
19. Martínez, E. G. C. M. J. 1993. Rapid transformation of non-Saccharomyces yeast by electroporation. Biotechnol. Techniques 7, 895-896.
20. Cregg, J. M. and Russell, K. A. 1998. Transformation. Methods Mol. Biol. 103, 27-39.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Alvarez-Obregon, J. C., Duenas-Carrera, S., Valenzuela, C., and Grillo, J. M. 2001. A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice. Vaccine 19, 3940-3946.
23. Kundig, T. M., Bachmann, M. F., Oehen, S., et al. 1996. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. U.S.A. 93, 9716-9723.
24. Brazzoli, M., Helenius, A., Foung, S. K., Houghton, M., Abrignani, S., and Merola, M. 2005. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Virology 332, 438-453.
25. Zahn, A. and Allain, J. P. 2005. Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J. Gen. Virol. 86, 677-685.
26. Acosta-Rivero, N., Musacchio, A., Lorenzo, L., Alvarez, C., and Morales, J. 2002. Processing of the hepatitis C virus precursor protein expressed in the methylotrophic yeast Pichia pastoris. Biochem. Biophys. Res. Commun. 295, 81-84.
27. Penin, F., Dubuisson, J., Rey, J. A., Moradpour, D., and Pawlotsky, J. M. 2004. Structural biology of hepatitis C virus. Hepatology 39, 5-19.
28. Slater-Handshy, T., Droll, D. A., Fan, X., Di Bisceglie, A. M., and Chambers, T. J. 2004. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 319, 36-48.
29. Yagnik, A. T., Lahm, A., Meola, A., et al. 2000. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355-366.
30. Duvet, S., Cocquerel, L., Pillez, A., et al. 1998. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem. 273, 32088-32095.
31. Choukhi, A., Ung, S., Wychowski, C., and Dubuisson, J. 1998. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J. Virol. 72, 3851-3858.
32. Goffard, A., Callens, N., Bartosch, B., et al. 2005. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79, 8400-8409.
33. Quinn, E. R., Chan, C. H., Hadlock, K. G., Foung, S. K., Flint, M., and Levy, S. 2001. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98, 3745-3749.
34. Tseng, C. T. and Klimpel, G. R. 2002. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43-49.
35. Wack, A., Soldaini, E., Tseng, C., Nuti, S., Klimpel, G., and Abrignani, S. 2001. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur. J. Immunol. 31, 166-175.
36. Duenas-Carrera, S., Vina, A., Garay, H. E., et al. 2001. Immunological evaluation of Escherichia coli-derived hepatitis C virus second envelope protein (E2) variants. J. Pept. Res. 58, 221-228.
37. Song, M. K., Lee, S. W., Suh, Y. S., Lee, K. J., and Sung, Y. C. 2000. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J. Virol. 74, 2920-2925.
38. Forns, X., Payette, P. J., Ma, X., et al. 2000. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32, 618-625.
39. Bhopale, G. M. and Nanda, R. K. 2004. Prospects for hepatitis C vaccine. Acta Virol. 48, 215-221.
40. Zinkernagel, R. M., Moskophidis, D., Kundig, T., Oehen, S., Pircher, H., and Hengartner, H. 1993. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol. Rev. 133, 199-223.